Erythrocin Alternatives Compared
Erythrocin | Amoxicillin / clavulanate | Augmentin |
|
---|
Erythrocin (erythromycin) | Amoxicillin / clavulanate | Augmentin (amoxicillin / clavulanate) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Bronchitis, Bowel Preparation, Bacterial Endocarditis Prevention, Bartonellosis, Bullous Pemphigoid, Campylobacter Gastroenteritis, Chancroid, Chlamydia Infection, Dental Abscess... View more |
Prescription only
Amoxicillin/clavulanate is a combination penicillin-type antibiotic that should be reserved for the treatment of infections caused by susceptible beta-lactamase-producing bacteria. Its use may be... View more |
Prescription only
Augmentin is a combination penicillin-type antibiotic that should be reserved for the treatment of infections caused by susceptible beta-lactamase-producing bacteria. Its use may be limited by... View more |
Related suggestions Skin or Soft Tissue Infection
Middle Ear Infections (Otitis Media)
|
|||||||||||||||
More about Erythrocin (erythromycin) | More about Amoxicillin / clavulanate | More about Augmentin (amoxicillin / clavulanate) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Erythrocin has an average rating of 6.7 out of 10 from a total of 3 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 0% reported a negative effect. |
Amoxicillin / clavulanate has an average rating of 5.3 out of 10 from a total of 901 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 42% reported a negative effect. |
Augmentin has an average rating of 5.4 out of 10 from a total of 442 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic approved |
Lower cost generic |
Lower cost generic approved | ||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Amoxicillin / clavulanate prices |
View all Augmentin prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Other erythromycin brands include: E-Mycin, E.E.S. Granules, E.E.S.-200, E.E.S.-400, E.E.S.-400 Filmtab, Ery-Tab, Eryc, EryPed, Erythrocin Lactobionate, Erythrocin Stearate Filmtab, Erythrocot, PCE Dispertab, Wyamycin S View more | Amoclan, Augmentin, Augmentin XR | Other amoxicillin / clavulanate brands include: Amoclan, Augmentin XR | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
2 hours |
1.7 hours |
1.7 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 649 drugs are known to interact with Erythrocin:
|
A total of 75 drugs are known to interact with Amoxicillin / clavulanate:
|
A total of 75 drugs are known to interact with Augmentin:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
August 06, 1984 |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
|
|
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.